LISATA THERAPEUTICS, INC. Operating Loss Carryforwards
LISATA THERAPEUTICS, INC. (LSTA) had Operating Loss Carryforwards of $34.00 million as of 2023-12-31, per its 10-K filed 2024-02-29.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2025-11-06
- 2023-12-31: Operating Loss Carryforwards $34.00M.
- 2022-12-31: Operating Loss Carryforwards $34.00M.
- 2021-12-31: Operating Loss Carryforwards $112.30M.
- 2019-12-31: Operating Loss Carryforwards $246.00M.
| Period end | Operating Loss Carryforwards | Operating Loss Carryforwards as first filed |
|---|---|---|
| 2023-12-31 | $34.00M 10-K · filed 2024-02-29 | |
| 2022-12-31 | $34.00M 10-Q · filed 2025-11-06 | |
| 2021-12-31 | $112.30M 10-K · filed 2023-03-30 | |
| 2019-12-31 | $246.00M 10-K · filed 2020-03-05 | |
| 2018-12-31 | $225.00M 10-K · filed 2020-03-05 | $225.10M 10-K · filed 2019-03-14 |
| 2017-12-31 | $210.30M 10-K · filed 2019-03-14 | |
| 2016-12-31 | $232.70M 10-K · filed 2018-03-22 | |
| 2015-12-31 | $221.50M 10-K · filed 2017-03-17 | |
| 2014-12-31 | $177.20M 10-K · filed 2016-03-15 | |
| 2013-12-31 | $110.60M 10-K · filed 2015-03-02 | |
| 2012-12-31 | $77.10M 10-K · filed 2014-03-13 | $69.70M 10-K · filed 2013-03-11 |
| 2011-12-31 | $47.43M 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |